Clinical trial
Oral Zinc Therapy for the Prevention of Mucositis
NCT00449592 · Sheba Medical Center, Other · Completed
Key facts
| NCT number | NCT00449592 |
|---|---|
| Title | Oral Zinc Therapy for the Prevention of Mucositis |
| Official title | A Ramdomized Double Blined Placebo Controlled Oral Zinc Therapy for the Prevention of Mucositis in Patients Undergoing High Dose Chemotherapy With Stem Cell Support |
| Lead sponsor | Sheba Medical Center, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Mucositis |
| Intervention type | Drug |
| Interventions | Zinc, Placebo |
| Enrollment | 40 |
| Start date | Apr 1, 2007 |
| Primary completion | Sep 1, 2008 |
| Completion | Sep 1, 2008 |
| First posted | Mar 20, 2007 |
| Last update posted | Oct 3, 2008 |
| Countries | Israel |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: